| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
36,440,000 |
| Market
Cap: |
347.64(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.54 - $9.54 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile SeaSpine Holdings is a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. Co. has a portfolio of orthobiologics and spinal implant solutions, as well as a surgical navigation system to perform fusion procedures in the lumbar, thoracic and cervical spine. Co.'s orthobiologics products consist of a range of bone graft substitutes including spine, hip, and extremities procedures. Co.'s spinal implants portfolio consists of a line of products and image-guided surgical solutions to help spinal fusion in degenerative, minimally invasive surgery, and spinal deformity procedures.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
53,786 |
| Total Sell Value |
$0 |
$0 |
$0 |
$316,788 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bradley Keith |
Director |
– • – |
2020-05-29 |
4 |
D |
$10.65 |
$4,047 |
D/D |
(380) |
51,849 |
|
- |
|
| Caruso Richard E |
10% Owner |
– – • |
2020-04-29 |
4 |
S |
$10.56 |
$51,959 |
D/D |
(4,921) |
15,457 |
|
-18% |
|
| Caruso Richard E |
10% Owner |
– – • |
2020-04-29 |
4 |
OE |
$9.43 |
$46,405 |
D/D |
4,921 |
20,378 |
|
- |
|
| Bradley Keith |
Director |
– • – |
2020-02-29 |
4 |
D |
$14.13 |
$763 |
D/D |
(54) |
52,229 |
|
- |
|
| Valentine Keith |
Chief Executive Officer |
• • – |
2020-01-01 |
4 |
D |
$12.01 |
$457,917 |
D/D |
(38,128) |
278,605 |
|
- |
|
| Valentine Keith |
Chief Executive Officer |
• • – |
2020-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
71,155 |
316,733 |
|
- |
|
| Keran Patrick L |
VP, General Counsel |
• – – |
2020-01-01 |
4 |
D |
$12.01 |
$187,032 |
D/D |
(15,573) |
58,895 |
|
- |
|
| Keran Patrick L |
VP, General Counsel |
• – – |
2020-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,834 |
74,468 |
|
- |
|
| Cirino Dennis |
SVP, Global Spinal Systems |
• – – |
2020-01-01 |
4 |
D |
$12.01 |
$16,802 |
D/D |
(1,399) |
12,085 |
|
- |
|
| Cirino Dennis |
SVP, Global Spinal Systems |
• – – |
2020-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,421 |
13,484 |
|
- |
|
| Lipschultz Tyler |
SVP, Orthobiologics and BD |
• – – |
2020-01-01 |
4 |
D |
$12.01 |
$139,592 |
D/D |
(11,623) |
94,689 |
|
- |
|
| Lipschultz Tyler |
SVP, Orthobiologics and BD |
• – – |
2020-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,687 |
106,312 |
|
- |
|
| Bostjancic John J. |
Chief Financial Officer |
• – – |
2020-01-01 |
4 |
D |
$12.01 |
$219,615 |
D/D |
(18,286) |
81,877 |
|
- |
|
| Bostjancic John J. |
Chief Financial Officer |
• – – |
2020-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,469 |
100,163 |
|
- |
|
| Winge John J. |
Vice President, Sales |
• – – |
2020-01-01 |
4 |
D |
$12.01 |
$163,312 |
D/D |
(13,598) |
66,275 |
|
- |
|
| Winge John J. |
Vice President, Sales |
• – – |
2020-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,430 |
79,873 |
|
- |
|
| Valentine Keith |
Chief Executive Officer |
• • – |
2019-12-31 |
4 |
A |
$10.21 |
$6,055 |
D/D |
593 |
245,578 |
|
- |
|
| Lipschultz Tyler |
SVP, Orthobiologics and BD |
• – – |
2019-12-31 |
4 |
A |
$10.21 |
$9,781 |
D/D |
958 |
74,625 |
|
- |
|
| Winge John J. |
Vice President, Sales |
• – – |
2019-12-31 |
4 |
A |
$10.21 |
$5,381 |
D/D |
527 |
51,443 |
|
- |
|
| Valentine Keith |
Chief Executive Officer |
• • – |
2019-12-13 |
4 |
B |
$11.12 |
$222,400 |
D/D |
20,000 |
244,985 |
2.81 |
- |
|
| Bradley Keith |
Director |
– • – |
2019-11-29 |
4 |
D |
$13.23 |
$714 |
D/D |
(54) |
52,283 |
|
- |
|
| Bradley Keith |
Director |
– • – |
2019-08-29 |
4 |
D |
$11.14 |
$602 |
D/D |
(54) |
52,337 |
|
- |
|
| Cirino Dennis |
SVP, Global Spinal Systems |
• – – |
2019-07-02 |
4 |
D |
$12.79 |
$58,412 |
D/D |
(4,567) |
10,063 |
|
- |
|
| Cirino Dennis |
SVP, Global Spinal Systems |
• – – |
2019-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,206 |
14,630 |
|
- |
|
| Cirino Dennis |
SVP, Global Spinal Systems |
• – – |
2019-06-28 |
4 |
A |
$11.26 |
$16,038 |
D/D |
1,424 |
1,424 |
|
- |
|
328 Records found
|
|
Page 7 of 14 |
|
|
